The differences of anaesthetic care in paediatrics compared to adults

Sue Clarke1

  • 1Salford Royal NHS Foundation Trust, Stott Lane, Salford M6 8HD. susisusic@aol.com

Insights

This study explores holistic perioperative care for pediatric patients, highlighting anatomical, physiological, and pharmacological differences from adults. It emphasizes patient safety and improving the overall experience through careful planning and adaptation.

Area of Science:

  • Pediatric Anesthesiology
  • Perioperative Medicine
  • Patient Safety

Background:

  • Perioperative care for pediatric patients presents unique challenges distinct from adult care.
  • Understanding developmental differences is crucial for safe and effective management.
  • Holistic care considers the multifaceted needs of children undergoing surgery.

Purpose of the Study:

  • To provide a comprehensive overview of holistic perioperative care for pediatric patients.
  • To address the specific anatomical, physiological, and pharmacological considerations in this population.
  • To discuss strategies for improving the perioperative experience for children.

Main Methods:

  • Review of current literature on pediatric perioperative care.
  • Discussion of key principles including patient safety, planning, and equipment adaptation.
  • Exploration of psychological challenges faced by pediatric patients.

Main Results:

  • Pediatric perioperative care requires specialized knowledge of developmental variations.
  • Patient safety is paramount and necessitates tailored approaches.
  • Addressing psychological aspects significantly impacts the overall patient experience.

Conclusions:

  • A holistic approach is essential for optimizing pediatric perioperative care.
  • Recognizing and managing pediatric-specific differences improves outcomes.
  • Continuous improvement in planning, equipment, and psychological support enhances the perioperative journey for children.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...